Your browser doesn't support javascript.
loading
Protocol for the AKT-MP trial: Access to Kidney Transplantation in Minority Populations.
Loor, Jamie M; Judd, Nila S; Rice, Claudia M; Perea, Diana D; Croswell, Emilee; Singh, Pooja P; Unruh, Mark; Zhu, Yiliang; Sehgal, Ashwini R; Goff, Sarah L; Bryce, Cindy L; Myaskovsky, Larissa.
Afiliação
  • Loor JM; Center for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
  • Judd NS; Center for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
  • Rice CM; Center for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
  • Perea DD; Center for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
  • Croswell E; Department of Psychiatry, University of Pittsburgh, United States.
  • Singh PP; Department of Internal Medicine, University of New Mexico, School of Medicine, United States.
  • Unruh M; Department of Internal Medicine, University of New Mexico, School of Medicine, United States.
  • Zhu Y; Department of Internal Medicine, University of New Mexico, School of Medicine, United States.
  • Sehgal AR; Department of Medicine, Case Western Reserve University, United States.
  • Goff SL; Department of Health Policy and Management, University of Massachusetts, Amherst, United States.
  • Bryce CL; Department of Health Policy and Management, University of Pittsburgh, School of Public Health, United States.
  • Myaskovsky L; Center for Healthcare Equity in Kidney Disease (CHEK-D), University of New Mexico Health Science Center, United States.
Contemp Clin Trials Commun ; 30: 101015, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36246997
ABSTRACT

Background:

Kidney transplant (KT) is the optimal treatment for kidney failure (KF), and although completion of KT evaluation is an essential step in gaining access to transplantation, the process is lengthy, time consuming, and burdensome. Furthermore, despite similar referral rates to non-Hispanic Whites, both Hispanic/Latinos and American Indians are less likely to be wait-listed or to undergo KT.

Methods:

The Access to Kidney Transplantation in Minority Populations (AKT-MP) Trial compares two patient-centered methods to facilitate KT evaluation kidney transplant fast track (KTFT), a streamlined KT evaluation process; and peer navigators (PN), a peer-assisted evaluation program that incorporates motivational interviewing. This pragmatic randomized trial will use a comparative effectiveness approach to assess whether KTFT or PN can help patients overcome barriers to transplant listing. We will randomly assign patients to the two conditions. We will track participants' medical records and conduct surveys prior to their initial evaluation clinic visit and again after they complete or discontinue evaluation.

Conclusion:

Our aims are to (1) compare KTFT and PN to assess improvements in kidney transplant (KT) related outcomes and cost effectiveness; (2) examine how each approach effects changes in cultural/contextual factors, KT concerns, KT knowledge, and KT ambivalence; and (3) develop a framework for widespread implementation of either approach. The results of this trial will provide key information for facilitating the evaluation process, improving patient care, and decreasing disparities in KT.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article